Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 180, Issue 5, Pages 752-755Publisher
WILEY
DOI: 10.1111/bjh.14441
Keywords
PD-1 inhibitor; pneumonitis; pembrolizumab; immune-related adverse event; lymphoma
Categories
Funding
- NCI [1K23CA157631]